| FIBROGEN INC. NEW O.N. |
| USA |
| Gesundheit |
| US31572Q8814 / A419WK |
| 1FG0 (Frankfurt) / FGEN (NASDAQ) |
| FRA:1FG0, ETR:1FG0, 1FG0:GR, NASDAQ:FGEN |
| - |
| https://www.fibrogen.com/ |
|
FibroGen, Inc., a biopharmaceutical company, disco..
>Volltext.. |
| 38.63 Mio. EUR |
| 133.27 Mio. EUR |
| 46.5 Mio. EUR |
| -25.42 Mio. EUR |
| -1.79 Mio. EUR |
| -0.45 EUR |
| 80.87 Mio. EUR |
| 20.29 Mio. EUR |
| -20.39 Mio. EUR |
| 0.15 |
| -71.98% |
| 98.88% |
| - |
| - |
| - |
| - |
| FIBROGEN |
| 08.11.25 |
|
||||
|